Andrew Reisner

Title: The Innovative Contributions of Andrew Reisner

Introduction

Andrew Reisner is an accomplished inventor based in Atlanta, GA (US). He has made significant contributions to the field of medical diagnostics, particularly in the area of traumatic brain injuries. His work focuses on developing methods that enhance the diagnosis and prediction of outcomes for patients suffering from such injuries.

Latest Patents

Andrew Reisner holds a patent for "Blood biomarkers for severe traumatic brain injuries." This patent discloses the use of plasma osteopontin (OPN) levels for diagnosing and predicting the severity and outcomes in traumatic brain injury (TBI). The method is applicable to various subjects, including pediatric, adult, and geriatric populations. Notably, it is particularly beneficial for pediatric subjects, where existing diagnostic methods are often inadequate. One of the key advantages of this method is its ability to diagnose Abusive Head Trauma (AHT) in pediatric patients.

Career Highlights

Andrew Reisner is affiliated with Children's Healthcare of Atlanta, Inc., where he applies his expertise in medical research and innovation. His work has the potential to significantly improve the diagnosis and treatment of traumatic brain injuries, ultimately enhancing patient care and outcomes.

Collaborations

Andrew collaborates with notable colleagues, including Laura Blackwell and Iqbal Sayeed. Their combined efforts contribute to advancing research and innovation in the medical field.

Conclusion

In summary, Andrew Reisner is a pioneering inventor whose work in blood biomarkers for traumatic brain injuries is making a meaningful impact in medical diagnostics. His contributions are vital for improving the lives of patients, particularly children, facing the challenges of TBI.